Jiangsu Hengrui Medicine
600276.SS
#514
Rank
ยฃ31.62 B
Marketcap
ยฃ4.96
Share price
-0.22%
Change (1 day)
2.88%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07165. In 2022 the company made an earnings per share (EPS) of ยฃ0.07144 a decrease over its 2021 EPS that were of ยฃ0.08617.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075465.62%
2022ยฃ0.07144-17.1%
2021ยฃ0.08617-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0948025.58%
2018ยฃ0.0754927.55%
2017ยฃ0.0591921.64%
2016ยฃ0.0486613.57%
2015ยฃ0.0428439.86%
2014ยฃ0.0306321.33%
2013ยฃ0.0252517.7%
2012ยฃ0.0214525.56%
2011ยฃ0.0170826.22%
2010ยฃ0.0135310.3%
2009ยฃ0.0122757.92%
2008ยฃ0.00777011.06%
2007ยฃ0.00699685.81%
2006ยฃ0.00376587.94%
2005ยฃ0.00200333.97%
2004ยฃ0.00149529.78%
2003ยฃ0.00115219.78%
2002ยฃ0.0009619